{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T23:03:57Z","timestamp":1783724637259,"version":"3.55.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:00:00Z","timestamp":1734739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"CorEvitas"},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Amgen, Inc"},{"DOI":"10.13039\/501100005105","name":"Arena","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005105","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008021","name":"Bristol Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008021","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010795","name":"Chugai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Janssen Pharmaceuticals, Inc"},{"DOI":"10.13039\/501100023331","name":"LEO Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019507","name":"Ortho Dermatologics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sun Pharmaceutical Industries"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Fatigue is commonly reported in patients with Crohn\u2019s disease (CD) and ulcerative colitis (UC), including patients with inactive disease. We explored the impact of fatigue on healthcare utilization (HCU) and work productivity and activity impairment (WPAI).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Data collected between 2017 and 2022 were analyzed from the CorEvitas IBD Registry. We compared HCU and WPAI among subjects with high fatigue (PROMIS \u226555) versus low fatigue at enrollment and subjects whose fatigue score worsened or persisted versus low fatigue at 6 months. HCU was defined as an inflammatory bowel disease-related hospitalization or emergency room visit. WPAI included presenteeism, absenteeism, and lost WPAI. Logistic regression analysis was performed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Study patients (640 CD, 569 UC) reported high rates of fatigue, 47% in CD and 38% in UC, that persisted at least 6 months in 88%-89% of patients. Patients with UC with high fatigue had 3-fold higher rates of HCU and 2-3-fold more absenteeism and activity impairment than patients with low fatigue. Patients with CD with high fatigue had no difference in HCU but did experience 2-4-fold more absenteeism, presenteeism, work productivity loss, and activity impairment. On subgroup analysis of patients in remission, those with high fatigue did not have higher rates of HCU but continued to have higher rates of WPAI.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Fatigue is associated with an increase in HCU only in the setting of concomitantly active disease. On the other hand, fatigue is associated with a negative impact on WPAI in the setting of both active and inactive disease.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/crocol\/otae073","type":"journal-article","created":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T16:50:07Z","timestamp":1734799807000},"source":"Crossref","is-referenced-by-count":5,"title":["Impact of Fatigue on Work Productivity, Activity Impairment, and Healthcare Resource Utilization in Inflammatory Bowel Disease"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7758-3257","authenticated-orcid":false,"given":"Linda A","family":"Feagins","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Dell Medical School at the University of Texas at Austin , Austin, TX,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Page","family":"Moore","sequence":"additional","affiliation":[{"name":"CorEvitas LLC , Waltham, MA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaux M","family":"Crabtree","sequence":"additional","affiliation":[{"name":"CorEvitas LLC , Waltham, MA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Eliot","sequence":"additional","affiliation":[{"name":"CorEvitas LLC , Waltham, MA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste A","family":"Lemay","sequence":"additional","affiliation":[{"name":"CorEvitas LLC , Waltham, MA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita M","family":"Loughlin","sequence":"additional","affiliation":[{"name":"CorEvitas LLC , Waltham, MA,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill K J","family":"Gaidos","sequence":"additional","affiliation":[{"name":"Section of Digestive Diseases, Yale University School of Medicine , New Haven, CT,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,12,21]]},"reference":[{"issue":"5","key":"2024123014255013000_CIT0001","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1097\/JOM.0000000000000981","article-title":"Effect of chronic diseases on work productivity: a propensity score analysis","volume":"59","author":"Fouad","year":"2017","journal-title":"J Occup Environ Med."},{"issue":"6","key":"2024123014255013000_CIT0002","doi-asserted-by":"publisher","first-page":"e0198975","DOI":"10.1371\/journal.pone.0198975","article-title":"The association of fatigue, pain, depression and anxiety with work and activity impairment in immune mediated inflammatory diseases","volume":"13","author":"Enns","year":"2018","journal-title":"PLoS One."},{"issue":"4","key":"2024123014255013000_CIT0003","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.crohns.2011.02.008","article-title":"High prevalence of fatigue in inflammatory bowel disease: a case control study","volume":"5","author":"Romkens","year":"2011","journal-title":"J Crohns Colitis."},{"issue":"1","key":"2024123014255013000_CIT0004","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/apt.16145","article-title":"Fatigue in inflammatory bowel disease and its impact on daily activities","volume":"53","author":"Schreiner","year":"2021","journal-title":"Aliment Pharmacol Ther."},{"issue":"4","key":"2024123014255013000_CIT0005","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41575-018-0091-9","article-title":"Fatigue in IBD: epidemiology, pathophysiology and management","volume":"16","author":"Borren","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"3","key":"2024123014255013000_CIT0006","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/ecco-jcc\/jjz148","article-title":"Longitudinal trajectory of fatigue with initiation of biologic therapy in inflammatory bowel diseases: a prospective cohort study","volume":"14","author":"Borren","year":"2020","journal-title":"J Crohns Colitis."},{"issue":"8","key":"2024123014255013000_CIT0007","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1093\/ecco-jcc\/jjz024","article-title":"Prevalence and factors associated with fatigue in patients with inflammatory bowel disease: a multicentre study","volume":"13","author":"Chavarria","year":"2019","journal-title":"J Crohns Colitis."},{"issue":"11","key":"2024123014255013000_CIT0008","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1093\/ecco-jcc\/jjad094","article-title":"Fatigue in patients with newly diagnosed inflammatory bowel disease: results from a prospective inception cohort, the IBSEN III study","volume":"17","author":"Holten","year":"2023","journal-title":"J Crohns Colitis."},{"issue":"1","key":"2024123014255013000_CIT0009","doi-asserted-by":"publisher","first-page":"10577","DOI":"10.1038\/s41598-022-14838-y","article-title":"Symptoms associated with healthcare resource utilization in the setting of inflammatory bowel disease","volume":"12","author":"Bogale","year":"2022","journal-title":"Sci Rep."},{"issue":"3","key":"2024123014255013000_CIT0010","doi-asserted-by":"publisher","first-page":"otad020","DOI":"10.1093\/crocol\/otad020","article-title":"Economic burden of fatigue in inflammatory bowel disease","volume":"5","author":"Ananthakrishnan","year":"2023","journal-title":"Crohns Colitis 360."},{"issue":"3","key":"2024123014255013000_CIT0011","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1093\/ibd\/izab074","article-title":"Trends in U.S. health care spending on inflammatory bowel diseases, 1996-2016","volume":"28","author":"Singh","year":"2022","journal-title":"Inflamm Bowel Dis."},{"issue":"1","key":"2024123014255013000_CIT0012","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/ecco-jcc\/jjv168","article-title":"Practical guideline for fatigue management in inflammatory bowel disease","volume":"10","author":"Kreijne","year":"2016","journal-title":"J Crohns Colitis."},{"key":"2024123014255013000_CIT0013","doi-asserted-by":"publisher","first-page":"110524","DOI":"10.1016\/j.jpsychores.2021.110524","article-title":"A systematic review of psychological treatments to manage fatigue in patients with inflammatory bowel disease","volume":"147","author":"Emerson","year":"2021","journal-title":"J Psychosom Res."},{"issue":"7","key":"2024123014255013000_CIT0014","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1007\/s10620-024-08468-9","article-title":"People with inflammatory bowel disease prefer cognitive behavioral therapy for fatigue management: a conjoint analysis","volume":"69","author":"Emerson","year":"2024","journal-title":"Dig Dis Sci."},{"issue":"4","key":"2024123014255013000_CIT0015","doi-asserted-by":"publisher","first-page":"CD012005","DOI":"10.1002\/14651858.CD012005.pub2","article-title":"Interventions for fatigue in inflammatory bowel disease","volume":"4","author":"Farrell","year":"2020","journal-title":"Cochrane Database Syst Rev."},{"issue":"5","key":"2024123014255013000_CIT0016","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jval.2019.02.004","article-title":"PROMIS((R)) adult health profiles: efficient short-form measures of seven health domains","volume":"22","author":"Cella","year":"2019","journal-title":"Value Health."},{"issue":"4","key":"2024123014255013000_CIT0017","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/NNR.0000000000000517","article-title":"Influencing factors of inflammatory bowel disease-fatigue: a path analysis model","volume":"70","author":"Davis","year":"2021","journal-title":"Nurs Res."},{"issue":"4","key":"2024123014255013000_CIT0018","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/acr.24501","article-title":"Identifying minimal and meaningful change in a patient-reported outcomes measurement information system for rheumatoid arthritis: use of multiple methods and perspectives","volume":"74","author":"Bartlett","year":"2022","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"5","key":"2024123014255013000_CIT0019","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/01.MLR.0000062554.74615.4C","article-title":"Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation","volume":"41","author":"Norman","year":"2003","journal-title":"Med Care."},{"issue":"12","key":"2024123014255013000_CIT0020","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1002\/ibd.20520","article-title":"Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis","volume":"14","author":"Lewis","year":"2008","journal-title":"Inflamm Bowel Dis."},{"issue":"8167","key":"2024123014255013000_CIT0021","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/s0140-6736(80)92767-1","article-title":"A simple index of Crohn\u2019s-disease activity","volume":"1","author":"Harvey","year":"1980","journal-title":"Lancet."},{"issue":"5","key":"2024123014255013000_CIT0022","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","article-title":"The validity and reproducibility of a work productivity and activity impairment instrument","volume":"4","author":"Reilly","year":"1993","journal-title":"PharmacoEcon."},{"issue":"2","key":"2024123014255013000_CIT0023","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.clinthera.2008.02.016","article-title":"Validity, reliability, and responsiveness of the work productivity and activity impairment questionnaire in Crohn\u2019s disease","volume":"30","author":"Reilly","year":"2008","journal-title":"Clin Ther."},{"issue":"5","key":"2024123014255013000_CIT0024","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.cgh.2021.06.034","article-title":"Prevalence and risk factors for fatigue in adults with inflammatory bowel disease: a systematic review with meta-analysis","volume":"20","author":"D\u2019Silva","year":"2022","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"8","key":"2024123014255013000_CIT0025","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/BF02599621","article-title":"Psychiatric disorders and medical care utilization among people in the general population who report fatigue","volume":"8","author":"Walker","year":"1993","journal-title":"J Gen Intern Med."},{"issue":"7","key":"2024123014255013000_CIT0026","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1097\/MIB.0000000000000399","article-title":"Presenteeism in inflammatory bowel diseases: a hidden problem with significant economic impact","volume":"21","author":"Zand","year":"2015","journal-title":"Inflamm Bowel Dis."},{"key":"2024123014255013000_CIT0027","doi-asserted-by":"publisher","first-page":"e594","DOI":"10.1097\/MEG.0000000000002178","article-title":"Work productivity loss is determined by fatigue and reduced quality of life in employed inflammatory bowel disease patients: a prospective multicentre cohort study","volume":"33","author":"van Gennep","year":"2021","journal-title":"Eur J Gastroenterol Hepatol."},{"issue":"8","key":"2024123014255013000_CIT0028","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/apt.17399","article-title":"Randomised clinical trial: psychological intervention improves work productivity and daily activity by reducing abdominal pain and fatigue in Crohn\u2019s disease","volume":"57","author":"Regev","year":"2023","journal-title":"Aliment Pharmacol Ther."}],"container-title":["Crohn's &amp; Colitis 360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/advance-article-pdf\/doi\/10.1093\/crocol\/otae073\/61253434\/otae073.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/article-pdf\/7\/1\/otae073\/61253434\/otae073.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/article-pdf\/7\/1\/otae073\/61253434\/otae073.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T14:26:06Z","timestamp":1735568766000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/article\/doi\/10.1093\/crocol\/otae073\/7930266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,21]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12,30]]}},"URL":"https:\/\/doi.org\/10.1093\/crocol\/otae073","relation":{},"ISSN":["2631-827X"],"issn-type":[{"value":"2631-827X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2024,12,21]]},"article-number":"otae073"}}